At a Glance Medications Offered Wegovy, Zepbound, Ozempic, Mounjaro Brand-Name Cost & Insurance Monthly: $99-$299 6-month estimate: $594-$1,794 Insurance: Employer / health-plan program dependent Self-pay: No clear national direct-to-consumer self-pay program identified Clinical Features Lab testing: No Dietitian access: Yes Verified Pharmacy: N/A Brand-name only (Wegovy, Zepbound, Ozempic, Mounjaro)
Metformin is stopped to prevent lactic acidosis, a rare but serious complication that can occur when surgical stress, anesthesia, or dehydration impairs kidney function, causing metformin to accumulate in the bloodstream
In December 2025, the FDA approved a new Depo-Provera label that included a warning of a potential meningioma risk
GLP-1 medications may be contraindicated if you have or have a history of: personal and family history of papillary and follicular thyroid cancers (given that there may be an increased risk based on animal studies) chronic nausea, vomiting or gastroparesis (as GLP-1s slow down gastric emptying and may worsen GI symptoms) pancreatitis (GLP-1s may increase the risk of pancreatitis or inflammation of the pancreas) children under 12 years old currently pregnant or breastfeeding eating disorders allergy or hypersensitivity to the medication weight cycling (losing and gaining weight back) without needing to lose weight for health reasons Always consult a healthcare professional before starting GLP-1 medications to ensure they align with your health needs and treatment plan
Glycation exacerbates the neuronal toxicity of -amyloid
Presumed sulfa allergy in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality
